We are dedicated to fostering an international forum of diverse stakeholders, converging for an in-depth presentation and dialogue on persistent surgical adhesion challenges that affect patients and healthcare systems worldwide. Our mission is to cultivate and share possible solutions, supported by individuals dedicated to healing and betterment.
The Surgical Adhesions Improvement Project Summit, September 19–20, in Washington, DC, aims to produce an adhesion consensus statement and a white paper that will centralize the state of the science, identify gaps, and suggest areas for improvement along with outlining current treatments, preventions, and best practices.
Attendees should be interested in fostering a multidisciplinary dialogue on the topic. The intended audience includes:
The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Surgeons designates this live activity for a maximum of 9.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program.
Upon completion of this summit, participants will be able to:
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.
Ineligible Company: The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Financial Relationships: Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
Conflict of Interest: Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
The following speakers received travel expenses:
Richard PG ten Broek, Radboud University, Netherlands - Nothing to Disclose
Deshka Foster, Longaker Laboratory, Stanford University - Nothing to Disclose
Steven Mutsaers, University of Western Australia - Nothing to Disclose
Eric Appel, Stanford University - Nothing to Disclose
Yuval Rinkevich, Helmholtz Zentrum, Munich - Nothing to Disclose
Steven Bauer, Wake Forest University School of Medicine - Nothing to Disclose
Dana Andersen, National Institute of Health - Nothing to Disclose
Jessica Cardenas, University of Colorado - Nothing to Disclose
Joel Zindel, University of Bern, Switzerland - Nothing to Disclose
Anthony Atala, Wake Forest University School of Medicine - Nothing to Disclose
Rudy Leon de Wilde, University Hospital for Gynecology, Germany - Nothing to Disclose
David Wiseman, International Adhesions Society - Nothing to Disclose
Walter Koltun, Pennsylvania State University - Nothing to Disclose
View our curated list of key publications from the experts speaking at the Summit. These publications highlight each speaker’s contributions, showcasing the impact of their work on clinical practices and patient outcomes.